Advertisement

CVS

CVS Health Corporation

Healthcare · USD

Set alert

Price alert · CVS

All alert types
90.25 USD -0.08 -0.09%
As of Oct 30, 2026 Extended hours 90.25 0.00%
Bid
90.23 × 300
Ask
90.27 × 200
89.90 Day range 91.95
70.08 52-week range 110.60
YTD
+13.72%
1 year
+17.68%
Open
91.95
Prev close
90.33
Mkt cap
115.43B
Vol
8.19M
Avg vol
7.94M
EPS
3.80
P/E
23.75
Div yield
2.94%
More statistics
Low
89.90
High
91.95
Forward P/E
10.60
Beta
0.60
Short ratio
1.63
Inst. own
91.08%
Dividend
2.66
Ex-div date
Oct 21, 2026
Earnings
Nov 4, 2026
50-d avg
91.29
200-d avg
88.73
1y target
115.48

MAX chart

Chart tools
Interval
CVS all-time price chart4.4131.759.086.3113.7Nov 84May 93Aug 01Feb 10May 18Oct 26

Key statistics

Market cap
115.70B
Enterprise value
178.07B
Trailing P/E
23.81
Forward P/E
10.60
PEG ratio
0.21
Price / sales
0.28
Price / book
1.45
EPS (TTM)
3.80
Beta
0.60
Dividend yield
2.94%
Payout ratio
70.00%
Profit margin
1.18%
Revenue (TTM)
412.64B
Revenue growth
7.10%
Free cash flow
8.08B
Total cash
13.96B
Total debt
76.31B
Return on equity
6.21%
Shares outstanding
1.28B
Short % of float
1.28%
50-day average
91.29
200-day average
88.73

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 115.48 +28.0% upside
Target (low)
103.00
Target (mean)
115.48
Target (high)
145.00
Ratings (0m) 27 25 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy18
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 1.65.

Earnings history

Financials — quick view

All financials
CVS Revenue — quarterly 106.10B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CVS Net income — quarterly 2.98B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CVS EPS — quarterly 2.33
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CVS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20261.65———
Aug 5, 2026Jun 30, 20261.852.58+0.73+39.46%
May 6, 2026Mar 31, 20262.182.57+0.39+17.89%
Feb 10, 2026Dec 31, 20251.001.09+0.09+9.00%
Oct 29, 2025Sep 30, 20251.371.60+0.23+16.79%
Jul 31, 2025Jun 30, 20251.461.81+0.35+23.97%

Upgrades / downgrades

CVS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Leerink PartnersmainOutperformOutperform
Sep 3, 2026UBSmainBuyBuy
Aug 19, 2026Argus ResearchmainBuyBuy
Aug 12, 2026JP MorganmainOverweightOverweight
Aug 6, 2026UBSmainBuyBuy
Aug 6, 2026Evercore ISI GroupmainOutperformOutperform

About CVS Health Corporation

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States

News

Your note

Sign in to keep a note on CVS — it syncs with the Stock Master app.

Insider holders

CVS insider holders
InsiderRelationLatest transactionDateShares held
BROWN C DAVID IIDirectorStock Award(Grant)May 13, 2026129,316
CAPOZZI HEIDI BOfficerStock Award(Grant)Mar 30, 202697,473
COMPTON-PHILLIPS AMYOfficerStock Award(Grant)Mar 30, 202658,660
COWHEY THOMAS F.Chief Financial OfficerStock Award(Grant)Mar 31, 202591,297
FARAH ROGER NDirectorStock Award(Grant)Nov 28, 202454,249
JOYNER JOHN DAVIDChief Executive OfficerStock Award(Grant)Mar 30, 2026231,209

Institution ownership

CVS institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.63%123,223,40911.15BJun 29, 2026
Vanguard Capital Management LLC6.51%83,315,3697.54BJun 29, 2026
Capital World Investors5.86%74,951,9556.78BJun 29, 2026
State Street Corporation4.71%60,283,4085.45BJun 29, 2026
Dodge & Cox Inc.3.91%50,012,7654.52BJun 29, 2026
Wellington Management Group, LLP2.64%33,801,1133.06BJun 29, 2026

Fund ownership

CVS fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%40,502,8673.66BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%33,064,6952.99BJun 29, 2026
Dodge & Cox Funds-Dodge & Cox Stock Fund2.48%31,708,0942.87BJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.47%31,634,0832.86BSep 29, 2026
Income Fund of America1.85%23,692,9962.14BSep 29, 2026
AMERICAN BALANCED FUND1.33%17,065,9481.54BSep 29, 2026
Advertisement